Expert panel clears Oxford-AstraZeneca’s COVID-19 vaccine for emergency use
NEW DELHI—In a significant development, the Subject Expert Committee of the Central Drug Standard Control Organisation on Friday recommended emergency use of Oxford-AstraZeneca’s ‘Covishield’ vaccine.
News agency IANS reported that the application would be sent to Drugs Controller General of India (DCGI) VG Somani for final approval.
COVID-19 has claimed 149,018 lives in India, besides infecting 10.3 million people so far. Indian government claims enforcement of early nationwide lockdown has managed to check the spread of coronavirus.